[Dexamethasone therapy in Huntington chorea: preliminary results]

Area of Science:

• Neurology
• Pharmacology

Context:

• Huntington's chorea (HC) is a neurodegenerative disorder characterized by involuntary movements (dyskinesia) and progressive functional decline.
• Current treatments, primarily neuroleptics, manage symptoms like chorea but do not halt disease progression or improve functional outcomes.
• Emerging evidence suggests a link between corticosteroids and the extrapyramidal system, prompting investigation into their therapeutic potential for HC.

Purpose:

• To investigate the efficacy of dexamethasone, a synthetic corticosteroid, in treating the motor symptoms of Huntington's chorea.
• To evaluate the impact of dexamethasone on dyskinesia and manual dexterity in HC patients.

Summary:

• Six female patients with Huntington's chorea received intramuscular dexamethasone at 4 mg/day for 20 days, followed by 8 mg/day for another 20 days.
• Dexamethasone administration resulted in statistically significant improvements in dyskinesia, as measured by the Abnormal Involuntary Movement Scale (AIMS).
• Manual dexterity, assessed using the Tapping test, also showed significant improvement in patients treated with dexamethasone.

Impact:

• Dexamethasone demonstrates potential as a novel therapeutic agent for Huntington's chorea, offering benefits in motor symptom control.
• The findings suggest that corticosteroids may offer a new therapeutic strategy for managing HC, potentially addressing limitations of current neuroleptic treatments.
• Further research is warranted to elucidate the precise mechanisms underlying dexamethasone's favorable effects in HC and to optimize its clinical application.